(Total Views: 368)
Posted On: 07/24/2019 10:15:40 AM
Post# of 33
$DMPI News Article - DelMar Pharmaceuticals Enrolls First Patient in the Recently-Approved Adjuvant Setting Arm of Phase 2 Study of VAL-083 for the Treatment of MGMT-Unmethylated Glioblastoma Multiforme https://marketwirenews.com/news-releases/delm...79993.html
(0)
(0)
My Twitter: WhyteStocks
